CMR reveals myocardial damage from cardiotoxic oncologic therapies in breast cancer patients.

Publikation

CMR reveals myocardial damage from cardiotoxic oncologic therapies in breast cancer patients.

Wissenschaftlicher Artikel/Review - 25.11.2023

Kersten Johannes, Fink Visnja, Kersten Maria, May Lisa, Nunn Samuel, Tadic Marijana, Huober Jens, Bekes Inga, Radermacher Michael, Hombach Vinzenz, Rottbauer Wolfgang, Buckert Dominik

Zitation

Kersten J, Fink V, Kersten M, May L, Nunn S, Tadic M, Huober J, Bekes I, Radermacher M, Hombach V, Rottbauer W, Buckert D. CMR reveals myocardial damage from cardiotoxic oncologic therapies in breast cancer patients. Int J Cardiovasc Imaging 2023

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Int J Cardiovasc Imaging 2023

Veröffentlichungsdatum

25.11.2023

eISSN (Online)

1875-8312

Kurzbeschreibung/Zielsetzung

Breast cancer is a common and increasingly treatable disease. However, survivors have a significantly elevated risk of cardiac events afterwards. This study aimed to characterise cardiac changes during cardiotoxic cancer therapy using cardiovascular magnetic resonance (CMR) imaging.